MEDITEX

This brand name is authorized in Nigeria.

Active ingredients

The drug MEDITEX contains one active pharmaceutical ingredient (API):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-3891	Injection	Meditex Injection+++ INJ 80 mg/mL 1 mL x 6 ampoules	Small volume injection 1 mL of colorless to light yellow transparent oily liquid is filled in the glass ampoule 79 CMS-PP-397491 MEDITEX INJECTION ARTEMETHER 80MG/ML Each ampoule (1ml) contains artemether 80mg 392Dec-96 Drugs Imported Products 1ml x 6 ampoules Prescription Only Medicine (POM) 1/8/2024 JUSTEEN PHARMACEUTICALS LTD, COKER ROAD ILUPEJU LAGOS LAGOS LAGOS 17747929 justeen2a@yahoo.com ANHUI CHENGSHI PHAERMACEUTICAL CO., LTD, N0. 5068, HUAISHANG ROAD, BENGBU. ANHUI PROVINCE. CHINA , China	25/09/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BE02	Artemether	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BE Artemisinin and derivatives
Discover more medicines within P01BE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-3891